Nabil A. Elshourbagy

Dr. Elshourbagy has more than 25 years of drug discovery experience. From 2000 to 2006, he was a Transnational Associate Director of Genomics at GlaxoSmithKline (GSK) where he supported the identification and validation of novel therapeutic targets. Prior to that, he was an Assistant Director of Molecular Biology at SmithKline Beecham (SB) where he successfully directed an international team resulting in the identification and validation of novel G-protein coupled receptors.

He received several awards including the Prix Galien Award for Excellence and Innovation in Research. Dr. Elshourbagy obtained his Ph.D. in Molecular Biology/Pharmacology from Cornell University, and postdoctoral training at the Medical Center of Virginia and the University of California, San Francisco. He is the author of over 100 papers and is an inventor on 22 issued US patents.